Lamotrigine
Is It Right for You?
A complete guide to Lamotrigine — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Lamotrigine?
Lamotrigine is an antiepileptic drug (AED) used in the management of epilepsy and, at higher doses, as a mood stabiliser for bipolar disorder. It is one of the most widely prescribed antiepileptic medications in the UK, valued for its broad spectrum of seizure activity, good tolerability profile relative to older antiepileptics, and — uniquely among mood stabilisers — its particular efficacy in preventing the depressive episodes of bipolar disorder.
Developed in the 1980s and approved for clinical use in the 1990s, lamotrigine represented a significant advance in epilepsy treatment. It is effective across multiple seizure types and is used both as monotherapy and as an add-on to other antiepileptics. In bipolar disorder, it is licensed as maintenance therapy — reducing the frequency and severity of mood episodes over the long term rather than treating acute episodes.
Lamotrigine requires careful, very gradual dose titration due to its most serious potential adverse effect — a severe, potentially life-threatening skin rash — whose risk is significantly reduced by slow dose escalation. It is available in tablet, dispersible tablet, and chewable tablet forms and is suitable for adults and children over 2 years (epilepsy).
Lamotrigine is a prescription-only medication in the UK. A licensed clinician must assess your clinical history before it can be prescribed — which can now be done quickly and conveniently through a telehealth consultation.
What Conditions Is Lamotrigine Used For?
Lamotrigine is licensed for:
with or without secondary generalisation.
as monotherapy or adjunctive therapy.
with Lennox-Gastaut syndrome.
in children (adjunctive therapy).
In bipolar disorder, lamotrigine is a maintenance treatment that prevents future mood episodes over time. It is not effective for treating an acute manic or depressive episode. It should never be discontinued abruptly in epilepsy, as sudden withdrawal can trigger seizures.
How Does Lamotrigine Work?
Lamotrigine exerts its antiepileptic and mood-stabilising effects through voltage-dependent blockade of neuronal sodium channels. Specifically, it preferentially binds to and stabilises the inactivated state of sodium channels — the state they adopt immediately after firing — prolonging their inactivation and reducing the frequency at which neurons can fire repetitive action potentials.
By reducing excessive, high-frequency neuronal firing without significantly impairing normal neuronal activity at resting or low firing rates, lamotrigine suppresses the pathological repetitive neuronal discharges that underlie seizures. This 'use-dependent' or 'state-dependent' blockade is characteristic of several antiepileptic drugs.
A secondary mechanism involves inhibition of the presynaptic release of glutamate — the principal excitatory neurotransmitter in the brain — particularly in limbic regions. By reducing glutamatergic neurotransmission, lamotrigine provides additional stabilisation of neuronal circuits involved in both seizure propagation and the mood dysregulation of bipolar disorder.
Unlike many other antiepileptics, lamotrigine does not primarily enhance GABAergic inhibition, and it has no significant effect on calcium channels or receptor-mediated neurotransmission at therapeutic doses.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Never increase the dose faster than specified — rapid titration is the primary risk factor for serious skin rash. Follow the prescribed escalation schedule exactly.
Take lamotrigine at the same time(s) each day to maintain consistent blood levels, which is critical for seizure control.
Never stop lamotrigine abruptly — in epilepsy, sudden withdrawal can trigger serious seizures including status epilepticus. In bipolar disorder, abrupt cessation may precipitate a rapid relapse. Always taper slowly under clinician supervision.
Report any rash immediately — even a minor rash during the first 8 weeks of treatment should prompt immediate contact with your clinician. Do not wait for an appointment.
Inform all treating clinicians of your lamotrigine dose — many drug interactions significantly alter lamotrigine blood levels.
Side Effects of Lamotrigine
Lamotrigine is generally well tolerated, particularly compared to older antiepileptics. The most important concern is the risk of serious skin reactions, particularly in the first 8 weeks of treatment and if the dose is escalated too rapidly.
- Headache
- Dizziness and coordination difficulties (ataxia)
- Diplopia (double vision)
- Nausea
- Insomnia or sleep disturbance
- Tremor
- Rash (mild maculopapular rash — common; serious rash — requires urgent assessment)
- Irritability or agitation (particularly in bipolar disorder)
- Stevens-Johnson Syndrome (SJS) / Toxic Epidermal Necrolysis (TEN) — severe, life-threatening mucocutaneous blistering reactions; risk is greatest in the first 8 weeks, with rapid dose escalation, or when used concurrently with valproate
- Aseptic meningitis — severe headache, stiff neck, fever, photophobia, nausea; rare but reported
- Haemophagocytic lymphohistiocytosis (HLH) — rare, serious inflammatory syndrome presenting with fever, rash, organ dysfunction
- Blood dyscrasias — rare; thrombocytopenia, neutropenia, aplastic anaemia
- Suicidal ideation — antiepileptic drugs as a class carry a small increased risk; monitor closely
Any rash occurring during the first 8 weeks of lamotrigine treatment must be taken seriously and reported to your clinician immediately — even if it appears mild. Approximately 10% of patients develop a rash; the majority are benign, but a small proportion progress to severe, life-threatening reactions including Stevens-Johnson Syndrome. Do not wait and observe — contact your clinician the same day any rash appears. If the rash is associated with fever, blistering, mouth sores, or skin peeling, seek emergency care immediately.
Drug Interactions
Lamotrigine has a particularly complex interaction profile. Many drugs significantly alter its metabolism, requiring dose adjustments. Always disclose all medications to your clinician and pharmacist.
These drugs significantly accelerate lamotrigine metabolism via CYP450 induction, approximately halving plasma lamotrigine levels. Higher lamotrigine doses are required when used concurrently. If an enzyme in,,ducer is withdrawn, lamotrigine levels will rise and dose reduction will be necessary.
Oestrogen-containing contraceptives significantly accelerate lamotrigine metabolism (by up to 50%), reducing lamotrigine plasma levels and potentially compromising seizure or mood control. Lamotrigine dose may need to be increased when starting COCs and reduced again during pill-free intervals. This interaction has caused unexpected seizures in women with epilepsy. A non-hormonal contraceptive or a progestogen-only method is often recommended; discuss with your clinician.
A potent enzyme inducer that reduces lamotrigine levels; dose adjustment required.
May increase lamotrigine levels; monitor for increased side effects.
Important Warnings
SJS and TEN are rare but potentially fatal skin reactions that can occur with lamotrigine. Risk factors include rapid dose escalation, concurrent valproate use, and a history of prior rash with another antiepileptic. Any rash during the first 8 weeks must be reported immediately. If blistering, mucosal involvement, or skin detachment occurs, call 999
Sudden withdrawal of lamotrigine in epilepsy carries a significant risk of prolonged seizures and status epilepticus. Always taper slowly under clinician supervision.
Women of childbearing age taking lamotrigine must be aware that combined oral contraceptives significantly reduce lamotrigine levels, potentially causing loss of seizure control or mood instability. This must be discussed with both prescribing and treating clinicians.
Lamotrigine is one of the safer antiepileptic drugs in pregnancy compared to valproate and carbamazepine, with lower risks of major fetal malformations. However, pregnancy substantially alters lamotrigine pharmacokinetics — levels may fall significantly, requiring dose increases. Close monitoring during pregnancy and post-partum is essential. Never stop lamotrigine in pregnancy without specialist guidance.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Lamotrigine FAQs
Slow dose titration is the single most important factor in reducing the risk of serious, potentially life-threatening skin rashes including Stevens-Johnson Syndrome. The risk of rash is significantly higher when doses are escalated rapidly. Although the slow titration schedule (typically 6 to 12 weeks) can feel frustrating when waiting for therapeutic benefit, it is a critical safety measure that should never be rushed.
Contact your clinician immediately — on the same day — even if the rash appears mild. Do not wait and observe. Most rashes are benign but a small proportion can progress rapidly to severe reactions. If the rash is accompanied by fever, blistering, mouth sores, or peeling skin, call 999 immediately.
Lamotrigine is a maintenance treatment — it works over time to reduce the frequency and severity of future mood episodes. It has particular efficacy for preventing depressive episodes in bipolar disorder. It is generally less effective for preventing manic episodes compared to lithium. It is not used to treat an acute episode of mania or depression — other medications are used for that purpose.
Combined oral contraceptives containing oestrogen significantly accelerate the metabolism of lamotrigine, potentially halving its plasma levels. This can lead to loss of seizure control or mood instability. This is a critical interaction that must be discussed with your clinician. The pill-free interval can also cause lamotrigine levels to spike, increasing the risk of side effects. Many neurologists recommend using non-hormonal contraception or a progestogen-only method (which does not significantly affect lamotrigine levels).
Yes. Lamotrigine is licensed for use in epilepsy in children over 2 years of age. Paediatric dosing is weight-based and requires careful titration. Dispersible and chewable tablet formulations are available for children. It is not licensed for bipolar disorder in those under 18.